Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1744-859X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study ; volume:20 ; number:1 ; day:24 ; month:4 ; year:2021 ; pages:1-7 ; date:12.2021
Annals of general psychiatry ; 20, Heft 1 (24.4.2021), 1-7, 12.2021
- Urheber
-
Bahta, Merhawi
Ogbaghebriel, Azieb
Russom, Mulugeta
Tesfamariam, Eyasu H.
Berhe, Tzeggai
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12991-021-00348-0
- URN
-
urn:nbn:de:101:1-2021061320172885930871
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bahta, Merhawi
- Ogbaghebriel, Azieb
- Russom, Mulugeta
- Tesfamariam, Eyasu H.
- Berhe, Tzeggai
- SpringerLink (Online service)
Ähnliche Objekte (12)
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence
Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence
Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence
Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia